Progressive supranuclear palsy
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Progressive supranuclear palsy is a brain disorder that affects movement, vision, speech, and thinking ability (cognition). The signs and symptoms of this disorder usually become apparent in mid- to late adulthood, most often in a person's 60s. Most people with progressive supranuclear palsy survive 5 to 9 years after the disease first appears, although a few affected individuals have lived for more than a decade.
Video picks for Genetic conditionsVideo library
Description
Progressive supranuclear palsy is a brain disorder that affects movement, vision, speech, and thinking ability (cognition). The signs and symptoms of this disorder usually become apparent in mid- to late adulthood, most often in a person's 60s. Most people with progressive supranuclear palsy survive 5 to 9 years after the disease first appears, although a few affected individuals have lived for more than a decade.
Loss of balance and frequent falls are the most common early signs of progressive supranuclear palsy. Affected individuals have problems with walking, including poor coordination and an unsteady, lurching gait. Other movement abnormalities develop as the disease progresses, including unusually slow movements (bradykinesia), clumsiness, and stiffness of the trunk muscles. These problems worsen with time, and most affected people ultimately require wheelchair assistance.
Progressive supranuclear palsy is also characterised by abnormal eye movements, which typically develop several years after the other movement problems first appear. Restricted up-and-down eye movement (vertical gaze palsy) is a hallmark of this disease. Other eye movement problems include difficulty opening and closing the eyelids, infrequent blinking, and pulling back (retraction) of the eyelids. These abnormalities can lead to blurred vision, an increased sensitivity to light (photophobia), and a staring gaze.
Additional features of progressive supranuclear palsy include slow and slurred speech (dysarthria) and trouble swallowing (dysphagia). Most affected individuals also experience changes in personality and behaviour, such as a general loss of interest and enthusiasm (apathy). They develop problems with cognition, including difficulties with attention, planning, and problem solving. As the cognitive and behavioural problems worsen, affected individuals increasingly require help with personal care and other activities of daily living.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Progressive supranuclear ophthalmoplegia
PSP
Richardson's syndrome
Steele-Richardson-Olszewski syndrome
Supranuclear palsy, progressive
Patient picks for Genetic conditions

Brain and nerves
Cerebral palsy
Cerebral palsy is a problem with muscle function. It is caused by brain injury or abnormal development of the brain that occurs while a child's brain is still developing. This may be before the baby is born, during the birth or soon after birth.
by Dr Hayley Willacy, FRCGP

Brain and nerves
Bell's palsy
Bell's palsy is a weakness (paralysis) that causes nerve damage; it affects the nerve fibres that control the muscles of the face. It is due to a problem with the facial nerve. It develops suddenly, usually on one side of the face. The cause is not clear but most cases are probably due to a viral infection. Most people make a full recovery within 2-3 months. A course of steroid tablets started within 72 hours of it starting improves the chance of full recovery even further. You should protect your eye if you cannot close your eyelids fully.
by Dr Toni Hazell, FRCGP

Brain and nerves
What you need to know about Bell's palsy
Bell's palsy affects as many as 24,800 people a year in the UK, but facial paralysis is still seen as a cosmetic issue - meaning knowledge of the condition, research funding and support for sufferers is scarce. We talk to Charles Nduka, founder of the charity Facial Palsy UK.
by Julian Turner
Related patient information and medicines

Patient information leaflet
Blepharospasm
Brain injury or tumour. Brain infections (viral encephalitis, Creutzfeldt-Jakob disease (CJD), AIDS HIV and AIDs , tuberculosis Tuberculosis , tetanus Tetanus and the tetanus vaccine ). Parkinson's disease Parkinson's disease /multiple system atrophy/progressive supranuclear palsy. Reaction to medications - eg, olanzapine Olanzapine , levodopa..

Patient information leaflet
Immunisation for flu
Exactly how well it works differs from year to. How is the flu vaccine created. Every year, the strains of influenza (flu) that cause infection change. This is because viruses are constantly mutating in order to increase their chances of causing infection. (If the flu virus stayed the same, then everyone who had been exposed to it would be immune..

Patient information leaflet
Dry mouth
Dry mouth has various causes. Simple measures such as drinking frequent sips of water, sucking ice cubes and chewing sugar-free gum will often help. If these nerves are damaged - such as by an operation, an injury, or another disease - they can cause the salivary glands to stop producing as much saliva. Bell's palsy Bell's palsy , a condition that.

Patient information leaflet
Motor neurone disease
Motor neurone disease (MND) is a neurological condition causes a progressive weakness and wasting of many of the muscles in the body. There are various types of motor neurone disease. This leaflet is mainly about amyotrophic lateral sclerosis (ALS), which is the most common type of motor neurone disease. Although there is no cure for motor neurone.

Patient information leaflet
Premature babies
However about 1 in 10 of all premature babies will have a permanent disability such as lung disease, cerebral palsy, blindness or deafness. One study of 241 children born before 26 weeks of gestation found: 1 in 5 had severe disability (for example, cerebral palsy + not walking, low cognitive scores, blindness, profound deafness). 1 in 4 had.

Patient information leaflet
Eye problems
Corneal infection Inflammation of the cornea is called keratitis and may be caused by various organisms, including germs such as bacteria and viruses. Corneal dystrophies These are a group of progressive conditions which cause a build-up of cloudy material in the cornea. However, it can occur after trauma or eyelid surgery (cicatricial... The main.
Further reading and references
- Progressive supranuclear palsy; MedlinePlus, National Library of Medicine.
- Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol. 1997 Feb;41(2):277-81. doi: 10.1002/ana.410410222.
- Donker Kaat L, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC. Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology. 2009 Jul 14;73(2):98-105. doi: 10.1212/WNL.0b013e3181a92bcc. Epub 2009 May 20.
- Ferrari R, Ryten M, Simone R, Trabzuni D, Nicolaou N, Hondhamuni G, Ramasamy A, Vandrovcova J; UK Brain Expression Consortium; Weale ME, Lees AJ, Momeni P, Hardy J, de Silva R. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy. Neurobiol Aging. 2014 Jun;35(6):1514.e1-12. doi: 10.1016/j.neurobiolaging.2014.01.010. Epub 2014 Jan 13.
- Golbe LI. Progressive supranuclear palsy. Semin Neurol. 2014 Apr;34(2):151-9. doi: 10.1055/s-0034-1381736. Epub 2014 Jun 25.
- Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P; PSP Genetics Study Group; Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Muller U, Schellenberg GD. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011 Jun 19;43(7):699-705. doi: 10.1038/ng.859.
- Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet. 2007 Apr;80(4):769-78. doi: 10.1086/513320. Epub 2007 Mar 8.
- Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009 Mar;8(3):270-9. doi: 10.1016/S1474-4422(09)70042-0.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

